hydroxychloroquine has been researched along with Familial Mediterranean Fever in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Familial Mediterranean Fever: A group of HEREDITARY AUTOINFLAMMATION DISEASES, characterized by recurrent fever, abdominal pain, headache, rash, PLEURISY; and ARTHRITIS. ORCHITIS; benign MENINGITIS; and AMYLOIDOSIS may also occur. Homozygous or compound heterozygous mutations in marenostrin gene encoding PYRIN result in autosomal recessive transmission; simple heterozygous, autosomal dominant form of the disease also exists with mutations in the same gene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, Y | 2 |
| Koga, T | 2 |
| Umeda, M | 1 |
| Furukawa, K | 1 |
| Sasaki, D | 1 |
| Yanagihara, K | 1 |
| Kawakami, A | 2 |
| Batu, ED | 1 |
| Ozen, S | 1 |
| Kiyani, A | 1 |
| Parperis, K | 2 |
| Erten, S | 1 |
| Taskaldiran, I | 1 |
| Yakut, ZI | 1 |
| Basaran, O | 1 |
| Aydın, F | 1 |
| Celikel, BA | 1 |
| Uncu, N | 1 |
| Cakar, N | 1 |
1 review available for hydroxychloroquine and Familial Mediterranean Fever
| Article | Year |
|---|---|
Are systemic lupus erythematosus patients carrying MEFV gene less prone to renal involvement? Report of three cases and review of the literature.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Colchicine; Cytoskeletal Pr | 2013 |
5 other studies available for hydroxychloroquine and Familial Mediterranean Fever
| Article | Year |
|---|---|
Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
Topics: Adult; Antirheumatic Agents; Asian People; Colchicine; Cytokines; Familial Mediterranean Fever; Fema | 2020 |
Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
Topics: Familial Mediterranean Fever; Humans; Hydroxychloroquine; Japan; Lupus Erythematosus, Systemic; Pyri | 2020 |
Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus: reply.
Topics: Familial Mediterranean Fever; Humans; Hydroxychloroquine; Japan; Lupus Erythematosus, Systemic; Pyri | 2020 |
Familial Mediterranean Fever Imitating Lupus Flare: A Rare Coexistence of an Autoimmune Disease With an Autoinflammatory Disease.
Topics: Adult; Antirheumatic Agents; Colchicine; Familial Mediterranean Fever; Female; Humans; Hydroxychloro | 2018 |
Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient.
Topics: Adolescent; Colchicine; Cyclophosphamide; Familial Mediterranean Fever; Female; Humans; Hydroxychlor | 2016 |